Page 5 - Api Holdings News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Why PharmEasy bought Thyrocare SUBSCRIBE Thank you for subscribing to Morning Dispatch We'll soon meet in your inbox. / Morning Dispatch PharmEasy, forked out Rs 4,546 crore for a controlling stake in diagnostics firm Thyrocare last week, becoming the first startup unicorn to acquire a listed legacy company in India. We spoke to Siddharth Shah, co-founder and CEO of API Holdings, on why he decided to buy, and to Arokiaswamy Velumani, promoter of Thyrocare, on why he decided to sell. Also in this letter: How Covid changed CEO salaries Google files first report under IT rules ��️ The R...

Exclusive content, features, opinions and comment - hand-picked by our editors, just for you. Pick 5 of your favourite companies. Get a daily email with all the news updates on them. Track the industry of your choice with a daily newsletter specific to that industry. Stay on top of your investments. Track stock prices in your portfolio. NOTE : The monthly duration product is an auto renewal based product. Once subscribed, subject to your card issuer's permission we will charge your card/ payment instrument each month automatically and re...

Exclusive content, features, opinions and comment - hand-picked by our editors, just for you. Pick 5 of your favourite companies. Get a daily email with all the news updates on them. Track the industry of your choice with a daily newsletter specific to that industry. Stay on top of your investments. Track stock prices in your portfolio. NOTE : The monthly duration product is an auto renewal based product. Once subscribed, subject to your card issuer's permission we will charge your card/ payment instrument each month automatically and re...

The total size of the transaction could be about $40 million and may value the company at about $1.8 billion, up from the current $1.5 billion valuation.

PharmEasy is said to have also begun exploratory talks to raise around Rs 3,000-Rs 3,700 crore through an IPO.